erythromycin has been researched along with Cholera in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad Hanapi, R; Mohamad, N; Ngoi, ST; Tan, SC; Teh, CSJ; Tham, KBL; Thong, KL; Wan Yussof, WN | 1 |
| Jin, Y; Kaviar, VH; Kouhsari, E; Li, YM; Maleki, A; Omidi, N; Vaziri, AZ; Yuan, XH | 1 |
| Hassan Kaviar, V; Khadivar, P; Kouhsari, E; Maleki, A; Omidi, N; Vaziri, AZ; Wu, Q | 1 |
| Ackhter, MM; Ahmed, T; Alam, T; Chisti, MJ; Dash, S; Golam Faruque, AS; Khan, SH; Parvin, I; Rahman, MW; Sarmin, M; Shahid, ASMSB; Shahrin, L; Shahunja, KM | 1 |
| Berkley, JA; Williams, PCM | 1 |
| Calderwood, SB; Chowdhury, F; Faruque, AS; Harris, JB; Khan, AI; Larocque, RC; Qadri, F; Ryan, ET | 1 |
| Bardhan, PK; Charles, RC; Harris, JB; Khan, AI; Larocque, RC; Mazumder, RN | 1 |
| Alam, M; Colwell, RR; Cravioto, A; Huq, A; Islam, MT; Johura, FT; Mannan, SB; Rashed, SM; Sack, RB; Sadique, A; Watanabe, H | 1 |
| Bennish, ML; Bogaerts, J; Khan, WA; Rahman, A; Saha, D; Salam, MA | 1 |
| Bhattacharya, MK; Bhattacharya, SK; Dutta, D; Ramamurthy, T; Sarkar, D; Singharoy, A | 1 |
| Begum, A; Chakraborty, B; Chowdhury, R; Chowdhury, S; Hossain, MJ; Khanam, M; Khatun, W; Mah-e-Muneer, S; Roy, SK; Shafique, S | 1 |
| Alam, AN; Haider, R; Kabir, I; Khan, WA; Mitra, AK | 1 |
| Aldighieri, S; Pesantes, C; Vela, E | 1 |
| Albert, MJ; Bhattacharya, MK; Khan, AM | 1 |
| Farooqui, BJ; Nizami, SQ | 1 |
| Nurahan, M; Ranjit, K | 1 |
| Ermol'eva, ZV; Libinzon, AE; Podosinnikova, LS; Popova, GO; Ved'mina, EA | 1 |
| Ermol'eva, ZV; Kereselidze, TS | 1 |
| Maleev, VV; Pokrovskiĭ, VI | 1 |
5 review(s) available for erythromycin and Cholera
| Article | Year |
|---|---|
Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cholera; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1; Vibrio cholerae O139 | 2022 |
Antimicrobial resistance among clinical
Topics: Anti-Bacterial Agents; Chloramphenicol; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae non-O1 | 2023 |
Guidelines for the management of paediatric cholera infection: a systematic review of the evidence.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Cholera; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Guidelines as Topic; Humans; Infant; Infant, Newborn; Treatment Outcome; Vibrio cholerae; World Health Organization | 2018 |
[Prevention of cholera by antibiotics].
Topics: Anti-Bacterial Agents; Carrier State; Chloramphenicol; Cholera; Clioquinol; Disease Outbreaks; Drug Resistance, Microbial; Erythromycin; Humans; Kanamycin; Nitrofurans; Paromomycin; Streptomycin; Tetracycline; Vibrio | 1971 |
[Contemporary principles of the therapy of cholera (review of the foreign literature)].
Topics: Ampicillin; Anti-Bacterial Agents; Benzoates; Bicarbonates; Blood Transfusion; Chloral Hydrate; Chloramphenicol; Cholera; Electrocardiography; Epinephrine; Erythromycin; Glucose; Humans; Hypertonic Solutions; Lactates; Magnesium Sulfate; Mobile Health Units; Norepinephrine; Oleandomycin; Potassium; Potassium Chloride; Promethazine; Sodium Chloride; Strophanthins; Tetracycline; Theophylline; Time Factors; Water-Electrolyte Balance | 1971 |
4 trial(s) available for erythromycin and Cholera
| Article | Year |
|---|---|
Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Child, Preschool; Cholera; Double-Blind Method; Drug Administration Schedule; Erythromycin; Feces; Humans; Infant; Male; Treatment Outcome; Vibrio cholerae O1; Vibrio cholerae O139 | 2002 |
Azithromycin in the treatment of cholera in children.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Cholera; Double-Blind Method; Erythromycin; Feces; Humans; India; Male; Severity of Illness Index; Treatment Outcome; Vibrio cholerae | 2003 |
Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.
Topics: Adolescent; Anti-Bacterial Agents; Bangladesh; Child; Child, Preschool; Cholera; Diarrhea; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Infant; Treatment Outcome; Zinc | 2008 |
Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Cholera; Erythromycin; Humans; Infant; Male; Pilot Projects; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
10 other study(ies) available for erythromycin and Cholera
| Article | Year |
|---|---|
Molecular characterization of Vibrio cholerae O1 El Tor strains in Malaysia revealed genetically diverse variant lineages.
Topics: Cholera; Cholera Toxin; Disease Outbreaks; Erythromycin; Genotype; Humans; Malaysia; Vibrio cholerae O1 | 2022 |
Changing Susceptibility Pattern of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Female; Furazolidone; Hospitals, Special; Humans; Male; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1 | 2020 |
Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Bacterial; Bangladesh; Child; Child, Preschool; Cholera; Cholera Toxin; Dehydration; Erythromycin; Feces; Female; Humans; Immunoglobulin G; Infant; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Serotyping; Tetracycline; Vibrio cholerae O1; Young Adult | 2010 |
Cholera's western front.
Topics: Administration, Oral; Anti-Bacterial Agents; Caribbean Region; Cholera; Disease Outbreaks; Doxycycline; Drug Administration Schedule; Erythromycin; Fluid Therapy; Global Health; Haiti; Humans; Infusions, Intravenous; Latin America; Pandemics; Public Health; Rehydration Solutions; Sanitation; Tetracycline; Vibrio cholerae O1; Water Supply; World Health Organization | 2010 |
Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Typing Techniques; Bangladesh; Base Sequence; beta-Lactamases; Cholera; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Erythromycin; Furazolidone; Genetic Variation; Gentamicins; Humans; Microbial Sensitivity Tests; Sequence Alignment; Sequence Analysis, DNA; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2012 |
[The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cholera; Drug Resistance, Microbial; Ecuador; Erythromycin; Humans; Nitrofurans; Nitrofurantoin; Penicillins; Polymyxin B; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
Neonatal diarrhea caused by Vibrio cholerae 0139 Bengal.
Topics: Anti-Bacterial Agents; Bangladesh; Cholera; Combined Modality Therapy; Diarrhea, Infantile; Erythromycin; Fluid Therapy; Humans; Infant, Newborn; Male; Vibrio cholerae | 1995 |
Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child; Child, Preschool; Cholera; Disease Outbreaks; Drug Resistance, Microbial; Erythromycin; Female; Gastroenteritis; Humans; Infant; Infant, Newborn; Male; Nalidixic Acid; Ofloxacin; Pakistan; Prevalence; Sanitation; Tetracycline Resistance; Vibrio cholerae; Water Supply | 1998 |
Tetracycline resistant cholera in Kelantan.
Topics: Anti-Bacterial Agents; Cholera; Drug Resistance, Microbial; Erythromycin; Humans; Malaysia; Microbial Sensitivity Tests; Tetracycline; Vibrio cholerae | 2000 |
[Sensitivity of cholera vibrios to antibiotics].
Topics: Aminosalicylic Acids; Ampicillin; Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Chlortetracycline; Cholera; Dihydrostreptomycin Sulfate; Erythromycin; Erythromycin Ethylsuccinate; Kanamycin; Liver Extracts; Neomycin; Oleandomycin; Oxacillin; Oxytetracycline; Penicillin Resistance; Penicillins; Polymyxins; Protamines; Streptomycin; Tetracycline; Vibrio; Water Microbiology | 1969 |